Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis ComplexMary Kay Koenig, Joan Roberson, Joshua Samuels et al.|JAMA Dermatology|2018Cited by 96
Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm TrialJohn M. Slopis, Mary Kay Koenig, Octavio Arevalo et al.|Drugs in R&D|2018Cited by 26